Status:
COMPLETED
Clinical Features of COVID-19 Patients
Lead Sponsor:
San Salvatore Hospital of L'Aquila
Conditions:
Covid19
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18-90 years
Brief Summary
The data were retrospectively collected during the first and the second wave of epidemic in COVID-19 patients with Severe Acute Respiratory Syndrome Coronavirus 2, at the moment of intensive care unit...
Detailed Description
At the moment of intensive care unit admission and during the in intensive care unit staying, the following data were collected: peripheral lymphocyte subsets were measured by multiple-color flow cyto...
Eligibility Criteria
Inclusion
- COVID-19 patients
- Acute respiratory distress syndrome
- needing of ventilatory support
Exclusion
- asymptomatic COVID-19 patients
- few symptoms
- mild symptoms
- without needing of ventilatory support
Key Trial Info
Start Date :
March 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04815304
Start Date
March 13 2020
End Date
November 13 2023
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Salvatore Academic Hospital
L’Aquila, Italy, 67100